XR Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,991
Closed -$644K 426
2023
Q1
$619K Buy
+3,991
New +$644K 0.02% 233
2022
Q3
Sell
-2,314
Closed -$411K 416
2022
Q2
$411K Sell
2,314
-848
-27% -$151K 0.14% 109
2022
Q1
$560K Buy
3,162
+1,331
+73% +$226K 0.1% 64
2021
Q4
$313K Buy
+1,831
New +$300K 0.03% 147
2021
Q3
Sell
-2,755
Closed -$454K 452
2021
Q2
$454K Sell
2,755
-265
-9% -$43.9K 0.2% 91
2021
Q1
$496K Sell
3,020
-2,411
-44% -$390K 0.03% 85
2020
Q4
$855K Buy
5,431
+3,556
+190% +$525K 0.06% 50
2020
Q3
$279K Buy
+1,875
New +$277K 0.02% 96
2020
Q1
Sell
-5,485
Closed -$800K 254
2019
Q4
$800K Buy
+5,485
New +$744K 0.1% 56
2019
Q1
Sell
-53,429
Closed -$6.89M 348
2018
Q4
$6.89M Buy
53,429
+47,525
+805% +$6.63M 3.01% 3
2018
Q3
$816K Buy
5,904
+1,317
+29% +$175K 0.21% 58
2018
Q2
$557K Buy
+4,587
New +$572K 0.2% 55

Other funds holding JNJ

XR Securities's JNJ Position: Q2 2023 in Review

XR Securities sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 3,991 shares — an estimated $644K sold.

XR Securities first reported a position in JNJ in Q2 2018 and held it in 12 quarters. The position peaked at $6.89M in Q4 2018. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • XR Securities reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 3,991 Johnson & Johnson shares in Q2 2023, an estimated $644K.
  • XR Securities first reported a position in Johnson & Johnson in Q2 2018 and held it in 12 quarters.
  • XR Securities's Johnson & Johnson position peaked at $6.89M in Q4 2018.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.